| Patent Number |
Title Of Patent |
Date Issued |
| 4542013 |
Trinitroglycerol sustained release vehicles and preparation therefrom |
September 17, 1985 |
| A trinitroglycerol-containing substantially disaccharide-free polymeric diffusion matrix is provided for the transdermal systemic delivery of trinitroglycerol through the skin of a patient. The polymeric diffusion matrix contains sufficient trinitroglycerol to be released over a prol |
| 4492685 |
Protective skin matrix |
January 8, 1985 |
| A protective skin matrix is provided which is particularly suited for the protection of burned or wounded patients. The matrix may be either cured, applied in sheets, or painted or sprayed directly onto the burned or wounded patient. The protective skin matrix includes polyvinylpyrrolido |
| 4482533 |
Polymeric diffusion matrix containing propranolol |
November 13, 1984 |
| A self-supporting polymeric diffusion matrix provides for the sustained release of propranolol in order to deliver said propranolol to a patient. The matrix comprises from about 1 to about 60% by weight of a polar plasticizer, from about 5 to about 20% by weight polyvinylalcohol having a |
| 4472372 |
Polymeric diffusion matrix containing chlorpheniramine maleate |
September 18, 1984 |
| There is disclosed a polymeric diffusion matrix for the sustained release of chlorpheniramine maleate by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of chlorphenira |
| 4460562 |
Polymeric diffusion matrix containing propranolol |
July 17, 1984 |
| A self-supporting polymeric diffusion matrix provides for the sustained release of propranolol in order to deliver the propranolol to a patient. The matrix comprises from about 1 to about 60% of a polar plasticizer, from about 6 to about 30% by weight polyvinylalcohol, from about 2 to |
| 4456587 |
Pheromone delivery system |
June 26, 1984 |
| This invention provides an aqueous mixture capable of being sprayed onto the leaves of plants and being cured in situ on the leaves. The thus cured mixture comprises polyvinylalcohol and polyvinylpyrrolidone. The cured mixture is capable of the sustained release of an active ingredient |
| 4442941 |
Anti-spilling drug capsule |
April 17, 1984 |
| A capsule for housing pellets is disclosed having two members, the first with a raised portion and the second with a connecting groove and an annular groove for interconnection with the raised portion to secure the two members together. |
| 4438139 |
Polymeric diffusion matrix containing estrogens |
March 20, 1984 |
| A polymeric diffusion matrix for the sustained release, intravaginal administration of an estrogen is provided. The matrix consists of polyvinylalcohol, polyvinylpyrrolidone and a polar plasticizer. |
| 4432965 |
Quinidine sustained release dosage formulation |
February 21, 1984 |
| A sustained release oral dosage form is provided comprising a tablet core containing a pharmaceutically effective amount of quinidine. The tablet core is coated with a sustained release polymeric coating which contains about 5 to about 20 percent by weight polyethylene glycol component h |
| 4428926 |
Sustained release propranolol system |
January 31, 1984 |
| Propranolol is delivered orally in a sustained release dosage form. The dosage form is for oral administration and comprises a core containing the drug and a coating of an expandable lattice, said expandable lattice permitting the passage of water therethrough but which under conditions |
| 4428925 |
Sustained release glycerol trinitrate |
January 31, 1984 |
| Glycerol trinitrate is delivered orally in a sustained release dosage form. The dosage form is for oral administration and comprises a core containing the drug and a coating of an expandable lattice, said expandable lattice permitting the passage of water therethrough but which under con |
| 4321252 |
Polymeric diffusion matrix containing ester derivatives of estradiol |
March 23, 1982 |
| There is disclosed a polymeric diffusion matrix for the sustained release of an estradiol ester by delivery to a patient requiring uterine wall maintenance or other types of estrogen therapy wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and |
| 4294820 |
Polymeric diffusion matrix containing phenylephrine |
October 13, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of phenylephrine by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of phenylephrine. |
| 4292303 |
Polymeric diffusion matrix containing clonidine |
September 29, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of clonidine by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of clonidine. |
| 4292302 |
Polymeric diffusion matrix containing terbutaline |
September 29, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of terbutaline by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of terbutaline. |
| 4292301 |
Polymeric diffusion matrix containing ephedrine |
September 29, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of ephedrine by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharamaceutically effective amount of ephedrine. |
| 4291015 |
Polymeric diffusion matrix containing a vasodilator |
September 22, 1981 |
| A polymeric diffusion matrix containing a vasodilator is provided comprising from about 2 to about 60% of a polar plasticizer, e.g., glycerol, from about 2 to about 15% of a matrix component, e.g., polyvinylalcohol, from about 2 to about 10% of a water-soluble polymer with hydration |
| 4291014 |
Polymeric diffusion matrix containing estradiol diacetate |
September 22, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of estradiol diacetate by delivery to a patient requiring uterine wall maintenance or other types of estrogen therapy wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and |
| 4289749 |
Polymeric diffusion matrix containing phenylpropanolamine |
September 15, 1981 |
| There is disclosed a polymeric diffusion matrix for the sustained release of phenylpropanolamine by transdermal delivery to a patient wherein the matrix comprises a polar plasticizer, polyvinylalcohol, polyvinylpyrrolidone, and a pharmaceutically effective amount of phenylpropanolami |
